|72.83||-2.31||-3.07%||Vol 3.93M||1Y Perf -4.67%|
|Feb 2nd, 2023 12:20 DELAYED|
|-0.15 -0.20%||- -|
|Target Price||100.00||Analyst Rating||Strong Buy 1.50|
|Potential %||37.52||Finscreener Ranking||★★★+ 50.35|
|Insiders Trans % 3/6/12 mo.||-100/-25/-80||Value Ranking||★+ 44.83|
|Insiders Value % 3/6/12 mo.||-100/-17/-82||Growth Ranking||★★★+ 55.27|
|Insiders Shares Cnt. % 3/6/12 mo.||-100/-16/-83||Income Ranking||— -|
|Price Range Ratio 52W %||-1.44||Earnings Rating||Buy|
|Market Cap||41.24B||Earnings Date||7th Feb 2023|
Today's Price Range
5 Year PE Ratio Range
|Moving Averages:||Strong Sell|
|Earnings History||Estimate||Reported||Surprise %|
|Earnings Per End||Estimate||Revision %||Trend|
|Next Report Date||7th Feb 2023|
|Estimated EPS Next Report||0.87|
|EPS Growth Next 5 Years %||13.40|
|Avg. Weekly Volume||3.72M|
|Avg. Monthly Volume||3.70M|
|Avg. Quarterly Volume||3.40M|
Centene Corporation (NYSE: CNC) stock closed at 75.14 per share at the end of the most recent trading day (a -1.44% change compared to the prior day closing price) with a volume of 3.84M shares and market capitalization of 41.24B. Is a component of S&P 500, Russell 1000 indices and it is traded on NYSE exchange. The company belongs in the Healthcare Plans industry, Healthcare sector and employs 71300 people. Centene Corporation CEO is Michael F. Neidorff.
The one-year performance of Centene Corporation stock is -4.67%, while year-to-date (YTD) performance is -8.38%. CNC stock has a five-year performance of 44.85%. Its 52-week range is between 73.195 and 98.53, which gives CNC stock a 52-week price range ratio of -1.44%
Centene Corporation currently has a PE ratio of 22.90, a price-to-book (PB) ratio of 1.76, a price-to-sale (PS) ratio of 0.40, a price to cashflow ratio of 5.40, a PEG ratio of 2.32, a ROA of 2.74%, a ROC of 5.24% and a ROE of 8.43%. The company’s profit margin is 1.30%, its EBITDA margin is 3.40%, and its revenue ttm is $108.99 Billion , which makes it $192.47 revenue per share.
Of the last four earnings reports from Centene Corporation, there were 4 positive earnings surprise and 0 negative earnings surprise. The company has EPS estimate of $0.87 for the next earnings report. Centene Corporation’s next earnings report date is 07th Feb 2023.
The consensus rating of Wall Street analysts for Centene Corporation is Strong Buy (1.5), with a target price of $100, which is +37.52% compared to the current price. The earnings rating for Centene Corporation stock is Buy (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).
Centene Corporation has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.
Centene Corporation has a Sell technical analysis rating based on Technical Indicators (ADX : 7.38, ATR14 : 1.86, CCI20 : -82.87, Chaikin Money Flow : -0.27, MACD : -1.47, Money Flow Index : 45.26, ROC : -2.47, RSI : 39.26, STOCH (14,3) : 12.29, STOCH RSI : 0.54, UO : 37.06, Williams %R : -87.71), Simple Moving Averages and Exponential Moving Averages.
Aggregated Insider Trades of Centene Corporation in the last 12-months were: Christopher J. Coughlin (Buy at a value of $976 440), H. James Dallas (Buy at a value of $250 564), Lori J. Robinson (Sold 1 200 shares of value $111 324 ), Mark J. Brooks (Sold 3 690 shares of value $305 200 ), Richard A. Gephardt (Sold 18 000 shares of value $1 517 060 ), Shannon Bagley (Sold 17 000 shares of value $1 477 810 ), Theodore R. Samuels (Buy at a value of $507 494)
Mon, 19 Dec 2022 14:20 GMT Analysts Are Bullish on These Healthcare Stocks: Centene (CNC), Staar Surgical (STAA)- TipRanks. All rights reserved.
Wed, 27 Jul 2022 12:45 GMT Analysts Are Bullish on Top Healthcare Stocks: Centene (CNC), Replimune Group (REPL)- TipRanks. All rights reserved.
Copyright © 2016-2023 Finscreener.org. All Rights Reserved.
Disclaimer: Before deciding to trade you should carefully consider your investment objectives, level of experience and your risk appetite. Forex and Tradegate data is a real-time with a 30 second refresh. Prices may not be accurate and may differ from the actual market price. Prices on the website are indicative and solely for informational purposes, not for trading purposes or advice. Please be aware of the risks associated with trading the on financial markets, it is one of the riskiest investment forms. Past performance does not guarantee future profits. We take no responsibility for any losses that may arise as a result of the data contained on this website. The content and the website are provided "as is", without any warranties. In no event will Finscreener.org, its employees, owners, directors, affiliates, partners, data provider, third party or anyone else liable to anyone else for any decision made regarding information on this website.
This could take some time, please wait.